Similar articles for PMID: 24808120

Year	Number of Results
1989	1
1993	1
1995	1
1996	1
1997	1
1998	2
1999	1
2000	2
2002	3
2003	2
2004	5
2005	2
2006	1
2007	4
2008	6
2009	5
2010	8
2011	2
2012	7
2013	4
2014	5
2015	4
2016	5
2017	5
2018	4
2019	6
2020	10
2021	0

1

Advanced therapy for inflammatory bowel disease: a guide for the primary care physician.

Thomas A, Lodhia N. Thomas A, et al. J Am Board Fam Med. 2014 May-Jun;27(3):411-20. doi: 10.3122/jabfm.2014.03.130224. J Am Board Fam Med. 2014. PMID: 24808120 Free article. Review.

2

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Caprilli R, et al. Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.

3

Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.

Markowitz J, Grancher K, Mandel F, Daum F. Markowitz J, et al. Am J Gastroenterol. 1993 Jan;88(1):44-8. Am J Gastroenterol. 1993. PMID: 8420272

4

[Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease].

Kim JH, Kim JW. Kim JH, et al. Korean J Gastroenterol. 2017 Oct 25;70(4):162-168. doi: 10.4166/kjg.2017.70.4.162. Korean J Gastroenterol. 2017. PMID: 29060953 Free article. Review. Korean.

5

Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Johnson CM, Dassopoulos T. Johnson CM, et al. Curr Gastroenterol Rep. 2018 Sep 28;20(11):53. doi: 10.1007/s11894-018-0658-1. Curr Gastroenterol Rep. 2018. PMID: 30267281 Review.

6

Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation.

Shaikh SA, Fitzgerald L, Tischer S. Shaikh SA, et al. Pharmacotherapy. 2017 Dec;37(12):1578-1585. doi: 10.1002/phar.2036. Epub 2017 Nov 21. Pharmacotherapy. 2017. PMID: 28960437 Free article. Review.

7

The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.

Kwon JH, Farrell RJ. Kwon JH, et al. Crit Rev Oncol Hematol. 2005 Oct;56(1):169-78. doi: 10.1016/j.critrevonc.2005.02.004. Crit Rev Oncol Hematol. 2005. PMID: 15979323 Review.

8

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.

Habal FM, Huang VW. Habal FM, et al. Aliment Pharmacol Ther. 2012 Mar;35(5):501-15. doi: 10.1111/j.1365-2036.2011.04967.x. Epub 2012 Jan 5. Aliment Pharmacol Ther. 2012. PMID: 22221203 Free article. Review.

9

Immunosuppressive drugs in the treatment of inflammatory bowel disease.

Aranda R, Horgan K. Aranda R, et al. Semin Gastrointest Dis. 1998 Jan;9(1):2-9. Semin Gastrointest Dis. 1998. PMID: 9547850 Review.

10

General principles of medical therapy of inflammatory bowel disease.

Friedman S. Friedman S. Gastroenterol Clin North Am. 2004 Jun;33(2):191-208, viii. doi: 10.1016/j.gtc.2004.02.003. Gastroenterol Clin North Am. 2004. PMID: 15177534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed